nference Artificial Intelligence AI technology (nferX) enables Knowledge Synthesis from unstructured text & structured biomedical databases. To tackle the challenge of synthesizing the world's biomedical knowledge, we knew that artificial intelligence (AI) could be a tremendous asset... but that AI alone would not be sufficient to achieve our goal. We recognized from Day 1 that we needed experts in the biomedical world to be an integral part of our team. That’s why nference is comprised of successful serial entrepreneurs from the tech space and PhDs in Biology/Genomics from MIT and Harvard Medical School. Our knowledge synthesis platform - nferX - uses state-of-the-art Neural Networks (shallow and deep learning models) for real-time, automated extraction of knowledge from the commercial, scientific, and regulatory body of literature. The platform enables a diverse set of applications ranging from R&D to commercial strategy and operations in the life sciences ecosystem. By synthesizing the world's biomedical knowledge, we empower our Pharma and Biotech customers to uncover insights across their entire pipeline and commercial portfolio. We believe in empowering our customers - bioinformaticians, data scientists, computational biologists, biostatisticians, business analysts... - to write their own custom apps via the nferX APIs. We believe our collective efforts will maximize the power of the nferX platform in our customers' businesses.

nference Artificial Intelligence AI technology (nferX) enables Knowledge Synthesis from unstructured text & structured biomedical databases. To tackle the challenge of synthesizing the world's biomedical knowledge, we knew that artificial intelligence (AI) could be a tremendous asset... but that AI alone would not be sufficient to achieve our goal. We recognized from Day 1 that we needed experts in the biomedical world to be an integral part of our team. That’s why nference is comprised of successful serial entrepreneurs from the tech space and PhDs in Biology/Genomics from MIT and Harvard Medical School. Our knowledge synthesis platform - nferX - uses state-of-the-art Neural Networks (shallow and deep learning models) for real-time, automated extraction of knowledge from the commercial, scientific, and regulatory body of literature. The platform enables a diverse set of applications ranging from R&D to commercial strategy and operations in the life sciences ecosystem. By synthesizing the world's biomedical knowledge, we empower our Pharma and Biotech customers to uncover insights across their entire pipeline and commercial portfolio. We believe in empowering our customers - bioinformaticians, data scientists, computational biologists, biostatisticians, business analysts... - to write their own custom apps via the nferX APIs. We believe our collective efforts will maximize the power of the nferX platform in our customers' businesses.

HEALTH[at]SCALE Technologies enables transformational improvements in healthcare outcomes, costs and satisfaction through advanced machine intelligence for care prediction designed to match every patient to the right treatment by the right provider at the right time.

HEALTH[at]SCALE Technologies enables transformational improvements in healthcare outcomes, costs and satisfaction through advanced machine intelligence for care prediction designed to match every patient to the right treatment by the right provider at the right time.